the informant: a true story, by eichenwald, k. new york: broadway books, 2000, xv+606 pp., $26.00...
TRANSCRIPT
Copyright # 2002 John Wiley & Sons, Ltd.
MANAGERIAL AND DECISION ECONOMICS
Manage. Decis. Econ. 23: 45–49 (2002)
BOOK REVIEWS
THE INFORMANT: A TRUE STORY, by Eichenwald, K.
New York: Broadway Books, 2000, xv+606 pp., $26.00 (cloth),
$14.95 (paper).
The competitors are our friends, and the customers are our
enemies.
We know when we’re lying.
} Corporate mottos of the Archer Daniels Midland Co.
The Informant begins in 1992 with allegations of industrial
espionage and extortion targeting the new Bioproducts Division
of the Archer Daniels Midland Company, self-styled
‘Supermarket to the World’. After investing more than $150
million and building the planet’s largest facility for producing
lysine, an amino acid used as a feed additive to promote weight
gain by chicken and pigs, output was lagging far below the
plant’s rated capacity of 113 000 metric tons per year. The
proprietary microbes necessary to convert dextrose into lysine
were dying like flies. Mark Whitacre, the manager of the
Bioproducts Division, told his bosses he had learnt why: a
phone call from an executive at one of ADM’s Japanese
competitors revealed the existence of a plot to introduce a
microbe-killing virus into the plant’s fermentation tanks. For a
payment of $10 million, the caller promised to name the mole
working for ADM responsible for disrupting its lysine
production process and to supply a virus-resistant microbe
that would solve the plant’s problems.
As The Informant unfolds, Mark Whitacre, the first Ph.D.
named to head one of the company’s main operating divisions,
rapidly becomes the central figure in a bizarre and convoluted
story eventually involving wire fraud, tax evasion, money
laundering, obstruction of justice, and price-fixing conspiracies.
In the end, Dr. Whitacre turns out to be a pathological liar of
truly Clintonian proportions. He lied to his bosses, to his
coworkers and associates, to the FBI, to his lawyers, and even
to his psychiatrist. Given the evidence he helped gather over the
course of several years as a cooperating witness, about the only
thing Whitacre seems to have told the truth about was his role
in negotiating an agreement between ADM and its Japanese
and Korean competitors to fix the price of lysine, about which
more later.
After hearing Whitacre’s charge of foreign sabotage and
extortion, the politically well-connected leadership of ADM,
Dwayne Andreas and his son Michael (‘Mick’), phoned Dwayne’s
nephew Allen, a lawyer who oversaw ADM’s European opera-
tions and had contacts at the CIA. That phone call subsequently
triggered an inquiry by the FBI’s Springfield, Illinois, field office
that, on the basis of information divulged by Whitacre, quickly
snowballed into two major criminal investigations.
In one of these cases, Whitacre was in due course sentenced
to prison for nine years and ordered to make restitution to
ADM, to the tune of $11 million, after pleading guilty to 37
felonies. Two vice presidents of the Bioproducts Division,
Marty Allison and Sid Hulse, also pled guilty to less lengthy
criminal indictments charging them with fraud, conspiracy, and
tax evasion. Hulse was sentenced to ten months in prison; in
return for cooperating with prosecutors, Allison received no jail
time. In the second case, Whitacre, Mick Andreas, and Terry
Wilson, the president of ADM’s corn-processing division, were
convicted of participating in an unlawful conspiracy to fix lysine
prices. The three men each received jail terms of two and a half
years, six months of which the trial judge permitted Whitacre to
serve concurrently with his earlier sentence. ADM was fined
$100 million. In addition, ADM’s two Japanese and two
Korean competitors struck deals with prosecutors whereby they
pled guilty to price fixing in return for fines of $10 million and
immunity for all but one of their executives, Kazutoshi Yamada
of Ajinomoto, Inc., allegedly the lysine conspiracy’s
‘quarterback’, the person responsible for collating and dis-
tributing information to the conspirators about industry output
volumes and market shares. Mr. Yamada was indicted but did
not appear at trial.
How did the informant himself end up bearing the brunt of
the penalties? One has to read the book. It is impossible in the
limited space of a review to tread more than lightly on the many
twists and turns in the path leading from the FBI’s ‘flipping’ of
Whitacre, convincing him secretly to record meetings at which
the terms of the lysine conspiracy were hammered out, to his
being named as a defendant in two federal criminal proceed-
ings. In brief, it seems that Whitacre started down the road to
personal ruin when he became a victim of the long-running
‘Nigerian Advance Fee Fraud’. That scam, in which someone
claiming to be connected to the Nigerian Ministry of Petroleum
Resources asks for help in bilking the ministry of millions of
dollars through a complex scheme involving bogus invoices,
cost Whitacre about $200 000. He also convinced some of his
friends and associates to contribute sums of $10 000 or $20 000
which the person running the scam would periodically say were
needed for the purpose of bribing Nigerian government officials
or defraying other expenses incurred in freeing up the money
that would make them all rich.
Finally realizing that the con-artist would keep asking for
money as long as his gullible victims were willing to pay it and
that his Nigerian boat would never come in, Whitacre decided
to recoup his losses by running the same scam on ADM. He
submitted phony invoices generated by dummy corporations he
set up to pose as suppliers or customers of the Bioproducts
Division, and then laundered the payments through bank
accounts in the Cayman Islands, Switzerland, Hong Kong, and
Australia. He double-billed ADM on legitimate transactions,
committing forgery in the process, and entered into numerous
kickback arrangements with ADM employees and consultants.
All told, Whitacre managed to steal some $9 million from his
company.
Whitacre’s downfall is also explained by his own bizarre
behavior, possibly attributable to a serious bipolar disorder for
which he was later hospitalized on two occasions. He played
both ends against the middle, supplying crucial audio and
videotaped evidence of ADM’s involvement in price fixing to
the FBI, all the while keeping his secretary and other people at
ADM at least partially informed about his cooperation with
government investigators. Thanks to Whitacre, ADM was
prepared for the FBI raid that brought the long-running
investigation officially to light. He faked at least one (and in all
likelihood two) suicide attempts to gain sympathy, told lies
about his daughter being harassed at her school, and falsely
claimed that he had been kidnapped and his life threatened.
During his manic phases, Whitacre lived in a fantasy world in
which delusions of grandeur led him to boast that, ‘when it was
all over’, a grateful board of directors would appoint him as
ADM’s new CEO. Showing his gardener a new briefcase the
FBI had given him containing one of the agency’s best
recording devices, Whitacre said that he should start calling
him ‘014’. ‘Why 014?’ ‘Because I’m twice as smart as 007’ (p.
143). Egotistical, anxious to please, paranoiac, and fulsome in
response to media attention, Whitacre’s charges of criminal
wrongdoing became both more outlandish and more contra-
dictory as the investigation proceeded. In the end, the
government’s star witness simply self-destructed.
The Informant presents a fascinating account of corporate
intrigue and the inner workings of a major antitrust investiga-
tion. While Whitacre and the agents who ran him often take
center stage, bureaucratic infighting between the FBI, the US
Attorney’s Office, and the Justice Department’s Antitrust
Division and its Fraud Section, the hardball tactics of defense
counsel, and the machinations at ADM are never far from view.
The author, a reporter for the New York Times, replays the
story as it happened, leaving the reader adrift in the web of lies
and deception, never quite sure where the line between the
fabulous and the factual should be drawn.
The key question raised by The Informant is, do Whitacre’s
allegations hang together in establishing the existence of an
unlawful price-fixing conspiracy? There seems to be no doubt
that Whitacre and several other ADM executives participated
in a series of meetings with their counterparts from Japan and
Korea for the purpose of negotiating agreements about lysine
prices and production volumes. As far as the law is concerned,
such evidence is all that is required to establish criminal
liability. Price fixing is illegal per se under the Sherman Act, and
prosecutors need not show that conspirators actually succeed in
raising prices above competitive levels.
Economists are more curious. Given the fragile nature of
price-fixing agreements, most would be predisposed to doubting
the effectiveness of a purported lysine cartel. According to Mick
Andreas, admittedly not the best witness on this point, ‘it was
impossible to fix prices . . . because too many variables wereinvolved’ (p. 307). The Informant contains only passing
references to lysine prices and profits, and certainly presents
no evidence that the price moves it does report were the ceteris
paribus result of the conspiracy’s operation. What seems clearer
is that the Korean producers were reluctant and sometimes
disruptive co-conspirators. ADM and the Japanese lysine
companies were never sure that the Koreans were reporting
their production volumes truthfully and, indeed, at one point
the Koreans stopped reporting numbers to the cartel’s
‘quarterback’ altogether. On another occasion, Whitacre
himself triggered a lysine price war in hopes that the Justice
Department would lose interest in the investigation, thereby
avoiding the scrutiny that might bring his other illegal activities
to light. In any case, one construction of the facts provided by
Eichenwald is that the Korean and Japanese producers had
been fixing prices prior to ADM’s entry into the lysine business,
and that all of the meetings that followed represented attempts
to cope with the emergence of a new competitor geared to
produce a volume of output that exceeded the collective
production capacity of the incumbents.
There is also a gaping hole in Eichenwald’s description of the
lysine cartel. A maudlin attempt to put a human face on the
victims of the alleged conspiracy by recounting the troubles of a
brother-in-law of the assistant special agent in charge of the
FBI’s Springfield Field Office, is one of the rare occasions on
which The Informant mentions the buyers of lysine. The
brother-in-law ‘had been a farmer most of his life, struggling
almost every day to get the crops in. He had been dependent on
banks, dependent on weather, dependent on feed companies.
Then recently, [he] and a friend had decided to take more
control of their futures by opening their own feed business’ (pp.
170–71). The agent’s kinsman may well have felt powerless in
the face of lysine prices that seemed to have ‘been going crazy’
(p. 171), but it is hard to believe that major lysine consumers
such as Hudson Foods and Tyson Foods stood idly by while
their suppliers conspired to profit at their expense. Indeed, the
conspirators ‘spent hours discussing regional prices and how to
handle customers who falsely claimed that they had been
offered a better price’, but arrived at no better solution than
pledging to hold firm against such demands (p. 222).
‘Everybody’s going to want to cheat anyway’, Terry Wilson
told Whitacre. ‘Knowing Mick, we’ll want to cheat’ (p. 220).
Allusions to Jeffersonian ideals notwithstanding, I harbor
little sympathy for the FBI agent’s brother-in-law who, besides
being dependent on the vagaries of the weather, is also, like his
fellow farmers, a virtual ward of the state. Nor do I feel sorry
for ADM. Perhaps the company, which enriched itself by using
the political process to elevate US sugar prices above the world
price, thereby inducing substitution in favor of high-fructose
corn syrup as a sweetener in soft drinks and many other food
products, and to secure federal subsidies for ethanol, a gasoline
additive derived from corn, thought that private price-fixing
agreements could be run like government-managed cartels. Still,
as a matter of economics, if not of law, The Informant fails to
convince me that ADM settled the lysine case for reasons other
than staunching the hemorrhaging of shareholders’ wealth that
followed revelations of being in the government’s crosshairs.
On the basis of evidence gathered during the investigation of
price-fixing in lysine, follow-on criminal cases produced guilty
pleas from, among others, drugs companies Hoffman-LaRoche,
which played ‘quarterback’, and an affiliate of Bayer AG, who
admitted to conspiring to fix the price of citric acid. Hoffman-
LaRoche and numerous other multinational corporations also
pled guilty to fixing the prices of vitamins. ‘Eventually, about 30
different grand juries investigated price fixing in almost every
corner of the food and feed industry; by 1999, the government
had obtained more than $1 billion in fines’ (p. 559).
The Informant is vivid testimony to Adam Smith’s famous
observation that ‘people of the same trade seldom meet
together, even for merriment and diversion, but the conversa-
tion ends in a conspiracy against the public or in some
contrivance to raise prices’. What almost everyone ignores is
BOOK REVIEWS46
Copyright # 2002 John Wiley & Sons, Ltd. Manage. Decis. Econ. 23: 45–49 (2002)
Smith’s warning in the next sentence: ‘It is impossible indeed to
prevent such meetings, by any law which either could be
executed, or would be consistent with liberty and justice’.
Meanwhile, Mark Whitacre resides in a federal minimum
security prison in Edgefield, South Carolina, where he has used
his spare time to earn degrees in psychology and law. Now that
his protagonist is licensed to steal, Kurt Eichenwald may well
have the opportunity to write several more riveting books. To
avoid being the subject of an equally sensational story, the
attendees at future trade association meetings are hereby given
notice to follow the advice offered jokingly by one of the parties
to the great lysine conspiracy: ‘pat ’em down for wires’ (p. 158).
William F. Shughart II
The University of Mississippi
School of Business Administration
PO Box 1848
University, MS 38677-1848 USA
DOI: 10.1002 mde : 1039
INVESTING FOR SUSTAINABILITY: THE MANAGE-
MENT OF MINERAL WEALTH, by Hannesson, R. Boston:
Kluwer Academic Publishers, 2001, ix+109 pp., $66.50 (cloth).
Most discussion of extractable (i.e. non-renewable) natural
resources focuses on the optimal rate of extraction of the
physical resource itself. Hannesson tackles a closely related
issue: how to convert the transitory wealth generated from
mineral extraction into permanent wealth. This is an important
question for many decision-makers, as transitory wealth is
created in a large number of contexts other than the extractive
industries. Highly popular movie and music stars, models,
professional athletes, and the like earn quasi-rents for limited
periods of time. So do winners of lotteries, television game
shows, and those who hit jackpots at gambling casinos and in
courtrooms. A large fraction of the population inherits wealth
from their parents. In each of these cases, wealth flows to the
recipient for a brief period of time.
The recipient of such transient wealth can consume it, in
which case his enhanced consumption also is transitory, or
invest some portion of it to create a perpetual flow of income
that can support future consumption. In his highly readable
book, Hannesson identifies the parameters that determine the
optimal fraction of transitory income to save in order to
generate a sustainable annual income. These parameters include
the period of time during which the individual expects to earn
transitory income, the expected rate of return on investments,
the period of time that income is saved, and the extent to which
the transitory income fluctuates over time. Hannesson’s
discussion of sustainability is couched in terms of creating an
infinitely lived stream of income that outlasts the finite mineral
resource. However, the general concepts are quite applicable to
the cases mentioned above. Someone who manages the financial
affairs of a professional athlete, for example, need only replace
the perpetual income to be earned with an income series
(annuity) that outlasts the athlete’s period of high earnings but
that expires at some finite point in the future. The principal
difference between these cases, is that in the case of an athlete
there is a single owner of the rent-generating resource, whereas
in the case of extractable resources the public frequently is the
residual claimant to the quasi-rents, either through direct
ownership or indirectly through taxation. More on this
presently.
In Chapter 1, Hannesson makes the utterly valid (and
thoroughly under-appreciated) point that sustainability is an
elusive concept with respect to extractive resources. This is
because rates of extraction unavoidably are based on known
reserves and prices of substitutes. However, an increase in the
price of a mineral resource induces new exploration which, at
least historically, leads to identification of additional reserves.
Moreover, an increase in the price of a mineral resource
simultaneously creates incentive for current users to economize
on the use of the resource and/or to seek out lower-priced
alternatives. Either way, this alters the optimal time-pattern of
extraction. Hannesson further makes a distinction between the
consumption (or extraction) of a nonrenewable resource and
the wealth derived from extraction of a nonrenewable resource.
Even though there may be a finite amount of the physical
resource, the transitory wealth generated from extraction can be
converted into a perpetual stream of income through invest-
ment.
In Chapter 2, Hannesson has a discussion of what mineral
rents are and identifies different types of mineral rents. This is
followed in Chapter 3 by his analysis of how much a country
can consume out of its current (or transitory) mineral revenues
without impoverishing itself in the long run. In Chapters 4–7,
Hannesson provides relevant institutional information about
and discusses the experiences of four investment funds based on
wealth generated from extractive industries: the Nauru phos-
phate funds, the Alaska Permanent Fund, the Alberta Heritage
Fund, and the Norwegian Petroleum Fund.
Finally, in Chapter 8, Hannesson draws from the experiences
of the three latter funds (all based on petroleum revenues) to
identify factors associated with success/failure of such funds. In
my opinion, the most thought-provoking and insightful
contributions are stuffed in this concise, to-the-point chapter.
For example, he notes that formal rules that stipulate a
minimum percentage of revenues be deposited into a Fund
almost certainly are superior to reliance upon the discretionary
whims of a legislative body that likely is more responsive to a
narrow collection of special interests than to the interests of a
truly sizable portion of the citizenry. He argues (p. 92), that ‘to
facilitate preservation of mineral wealth it is important to
design rules and institutions which enhance the public interest
in wealth conservation and strengthen the incentives parlia-
mentarians have for making decisions conducive to that
purpose’. If each person’s stake in the stream of wealth
generated by the fund is sufficiently small, there is little
incentive for the recipients to protect the fund from political
chicanery. This means that the pool of beneficiaries of the
fund’s returns cannot be too large. The political boundaries of
Alaska, Alberta and Norway were determined before the
discovery of their valuable petroleum, an historical accident
that fortuitously achieves the desired small pool of recipients
result.
BOOK REVIEWS 47
Copyright # 2002 John Wiley & Sons, Ltd. Manage. Decis. Econ. 23: 45–49 (2002)